{"id":6693,"date":"2022-03-29T18:57:02","date_gmt":"2022-03-29T17:57:02","guid":{"rendered":"https:\/\/www.ab-science.com\/?p=6693"},"modified":"2022-03-29T18:59:44","modified_gmt":"2022-03-29T17:59:44","slug":"communication-dab-science-a-la-suite-de-la-decision-de-la-commission-des-sanctions-de-lautorite-des-marches-financiers","status":"publish","type":"post","link":"https:\/\/www.ab-science.com\/fr\/communication-dab-science-a-la-suite-de-la-decision-de-la-commission-des-sanctions-de-lautorite-des-marches-financiers\/","title":{"rendered":"Communication d\u2019AB Science \u00e0 la suite de la d\u00e9cision de la Commission des sanctions de l\u2019Autorit\u00e9 des March\u00e9s Financiers"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row][vc_column][vc_column_text]<\/p>\n<h3 class=\"Default\">29\/03\/2022 \u2013<\/h3>\n<p>AB Science prend acte de la d\u00e9cision de la Commission des sanctions de l\u2019Autorit\u00e9 des March\u00e9s Financiers (AMF) mettant hors de cause son Pr\u00e9sident Directeur G\u00e9n\u00e9ral, Alain Moussy, dans une d\u00e9cision portant sur un possible manquement d\u2019initi\u00e9.<br \/>\n[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<iframe width=\"100%\" height=\"800\" src=\"https:\/\/www.ab-science.com\/themencode-pdf-viewer-sc\/?tnc_pvfw=ZmlsZT1odHRwczovL3d3dy5hYi1zY2llbmNlLmNvbS93cC1jb250ZW50L3VwbG9hZHMvMjAyMi8wMy9DUC1EZWNpc2lvbi1BTUYtVkZSLVZGLnBkZiZzZXR0aW5ncz0xMTEwMTExMTExMTExMTExMTAwJmxhbmc9ZW4tVVM=#page=&zoom=100&pagemode=none\" title=\"\"><\/iframe>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column]<style type=\"text\/css\" data-type=\"the7_shortcodes-inline-css\">#default-btn-2f61bfdde6365ce17973cc07695ed50c.ico-right-side > i {\n  margin-right: 0px;\n  margin-left: 8px;\n}\n#default-btn-2f61bfdde6365ce17973cc07695ed50c > i {\n  margin-right: 8px;\n}<\/style><div class=\"btn-align-center\"><a href=\"https:\/\/www.ab-science.com\/wp-content\/uploads\/2022\/03\/CP-Decision-AMF-VFR-VF.pdf\" class=\"default-btn-shortcode dt-btn dt-btn-l link-hover-off  vc_custom_1648576316277\" target=\"_blank\" id=\"default-btn-2f61bfdde6365ce17973cc07695ed50c\" rel=\"noopener\"><i class=\"dt-icon-the7-download\"><\/i><span>T\u00e9l\u00e9charger le PDF<\/span><\/a><\/div>[\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column][vc_column_text] 29\/03\/2022 \u2013 AB Science prend acte de la d\u00e9cision de la Commission des sanctions de l\u2019Autorit\u00e9 des March\u00e9s Financiers (AMF) mettant hors de cause son Pr\u00e9sident Directeur G\u00e9n\u00e9ral, Alain Moussy, dans une d\u00e9cision portant sur un possible manquement d\u2019initi\u00e9. [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text][\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[127],"tags":[117,116],"class_list":["post-6693","post","type-post","status-publish","format-standard","hentry","category-2022-fr","tag-ab10015","tag-riluzole","category-127","description-off"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.4 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Communication d\u2019AB Science \u00e0 la suite de la d\u00e9cision de la Commission des sanctions de l\u2019Autorit\u00e9 des March\u00e9s Financiers<\/title>\n<meta name=\"description\" content=\"AB Science annonce aujourd\u2019hui avoir re\u00e7u l\u2019autorisation de l\u2019Agence de Sant\u00e9 Su\u00e9doise pour initier une \u00e9tude de Phase III (AB20009\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ab-science.com\/fr\/communication-dab-science-a-la-suite-de-la-decision-de-la-commission-des-sanctions-de-lautorite-des-marches-financiers\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Communication d\u2019AB Science \u00e0 la suite de la d\u00e9cision de la Commission des sanctions de l\u2019Autorit\u00e9 des March\u00e9s Financiers\" \/>\n<meta property=\"og:description\" content=\"AB Science annonce aujourd\u2019hui avoir re\u00e7u l\u2019autorisation de l\u2019Agence de Sant\u00e9 Su\u00e9doise pour initier une \u00e9tude de Phase III (AB20009\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ab-science.com\/fr\/communication-dab-science-a-la-suite-de-la-decision-de-la-commission-des-sanctions-de-lautorite-des-marches-financiers\/\" \/>\n<meta property=\"og:site_name\" content=\"AB Science\" \/>\n<meta property=\"article:published_time\" content=\"2022-03-29T17:57:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-03-29T17:59:44+00:00\" \/>\n<meta name=\"author\" content=\"Alexis BERNARD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Alexis BERNARD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/communication-dab-science-a-la-suite-de-la-decision-de-la-commission-des-sanctions-de-lautorite-des-marches-financiers\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/communication-dab-science-a-la-suite-de-la-decision-de-la-commission-des-sanctions-de-lautorite-des-marches-financiers\\\/\"},\"author\":{\"name\":\"Alexis BERNARD\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#\\\/schema\\\/person\\\/f22e8dbe9aaad0d416cbea66ecc4a755\"},\"headline\":\"Communication d\u2019AB Science \u00e0 la suite de la d\u00e9cision de la Commission des sanctions de l\u2019Autorit\u00e9 des March\u00e9s Financiers\",\"datePublished\":\"2022-03-29T17:57:02+00:00\",\"dateModified\":\"2022-03-29T17:59:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/communication-dab-science-a-la-suite-de-la-decision-de-la-commission-des-sanctions-de-lautorite-des-marches-financiers\\\/\"},\"wordCount\":164,\"publisher\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#organization\"},\"keywords\":[\"AB10015\",\"riluzole\"],\"articleSection\":[\"2022\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/communication-dab-science-a-la-suite-de-la-decision-de-la-commission-des-sanctions-de-lautorite-des-marches-financiers\\\/\",\"url\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/communication-dab-science-a-la-suite-de-la-decision-de-la-commission-des-sanctions-de-lautorite-des-marches-financiers\\\/\",\"name\":\"Communication d\u2019AB Science \u00e0 la suite de la d\u00e9cision de la Commission des sanctions de l\u2019Autorit\u00e9 des March\u00e9s Financiers\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#website\"},\"datePublished\":\"2022-03-29T17:57:02+00:00\",\"dateModified\":\"2022-03-29T17:59:44+00:00\",\"description\":\"AB Science annonce aujourd\u2019hui avoir re\u00e7u l\u2019autorisation de l\u2019Agence de Sant\u00e9 Su\u00e9doise pour initier une \u00e9tude de Phase III (AB20009\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/communication-dab-science-a-la-suite-de-la-decision-de-la-commission-des-sanctions-de-lautorite-des-marches-financiers\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/communication-dab-science-a-la-suite-de-la-decision-de-la-commission-des-sanctions-de-lautorite-des-marches-financiers\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/communication-dab-science-a-la-suite-de-la-decision-de-la-commission-des-sanctions-de-lautorite-des-marches-financiers\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Communication d\u2019AB Science \u00e0 la suite de la d\u00e9cision de la Commission des sanctions de l\u2019Autorit\u00e9 des March\u00e9s Financiers\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/\",\"name\":\"AB Science\",\"description\":\"Masitinib and AB8939 \u2013 Two compounds with breakthrough mechanism of action\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#organization\",\"name\":\"AB Science\",\"url\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ab-science.com\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/logo_ab-science-wh120.png\",\"contentUrl\":\"https:\\\/\\\/www.ab-science.com\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/logo_ab-science-wh120.png\",\"width\":120,\"height\":120,\"caption\":\"AB Science\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ab-science\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#\\\/schema\\\/person\\\/f22e8dbe9aaad0d416cbea66ecc4a755\",\"name\":\"Alexis BERNARD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/586e211c7d685fdd3428b70716f97574cf1b3149b055c1be5bdc5a7306e419bd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/586e211c7d685fdd3428b70716f97574cf1b3149b055c1be5bdc5a7306e419bd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/586e211c7d685fdd3428b70716f97574cf1b3149b055c1be5bdc5a7306e419bd?s=96&d=mm&r=g\",\"caption\":\"Alexis BERNARD\"},\"url\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/author\\\/abernard\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Communication d\u2019AB Science \u00e0 la suite de la d\u00e9cision de la Commission des sanctions de l\u2019Autorit\u00e9 des March\u00e9s Financiers","description":"AB Science annonce aujourd\u2019hui avoir re\u00e7u l\u2019autorisation de l\u2019Agence de Sant\u00e9 Su\u00e9doise pour initier une \u00e9tude de Phase III (AB20009","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ab-science.com\/fr\/communication-dab-science-a-la-suite-de-la-decision-de-la-commission-des-sanctions-de-lautorite-des-marches-financiers\/","og_locale":"fr_FR","og_type":"article","og_title":"Communication d\u2019AB Science \u00e0 la suite de la d\u00e9cision de la Commission des sanctions de l\u2019Autorit\u00e9 des March\u00e9s Financiers","og_description":"AB Science annonce aujourd\u2019hui avoir re\u00e7u l\u2019autorisation de l\u2019Agence de Sant\u00e9 Su\u00e9doise pour initier une \u00e9tude de Phase III (AB20009","og_url":"https:\/\/www.ab-science.com\/fr\/communication-dab-science-a-la-suite-de-la-decision-de-la-commission-des-sanctions-de-lautorite-des-marches-financiers\/","og_site_name":"AB Science","article_published_time":"2022-03-29T17:57:02+00:00","article_modified_time":"2022-03-29T17:59:44+00:00","author":"Alexis BERNARD","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Alexis BERNARD","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ab-science.com\/fr\/communication-dab-science-a-la-suite-de-la-decision-de-la-commission-des-sanctions-de-lautorite-des-marches-financiers\/#article","isPartOf":{"@id":"https:\/\/www.ab-science.com\/fr\/communication-dab-science-a-la-suite-de-la-decision-de-la-commission-des-sanctions-de-lautorite-des-marches-financiers\/"},"author":{"name":"Alexis BERNARD","@id":"https:\/\/www.ab-science.com\/fr\/#\/schema\/person\/f22e8dbe9aaad0d416cbea66ecc4a755"},"headline":"Communication d\u2019AB Science \u00e0 la suite de la d\u00e9cision de la Commission des sanctions de l\u2019Autorit\u00e9 des March\u00e9s Financiers","datePublished":"2022-03-29T17:57:02+00:00","dateModified":"2022-03-29T17:59:44+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ab-science.com\/fr\/communication-dab-science-a-la-suite-de-la-decision-de-la-commission-des-sanctions-de-lautorite-des-marches-financiers\/"},"wordCount":164,"publisher":{"@id":"https:\/\/www.ab-science.com\/fr\/#organization"},"keywords":["AB10015","riluzole"],"articleSection":["2022"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.ab-science.com\/fr\/communication-dab-science-a-la-suite-de-la-decision-de-la-commission-des-sanctions-de-lautorite-des-marches-financiers\/","url":"https:\/\/www.ab-science.com\/fr\/communication-dab-science-a-la-suite-de-la-decision-de-la-commission-des-sanctions-de-lautorite-des-marches-financiers\/","name":"Communication d\u2019AB Science \u00e0 la suite de la d\u00e9cision de la Commission des sanctions de l\u2019Autorit\u00e9 des March\u00e9s Financiers","isPartOf":{"@id":"https:\/\/www.ab-science.com\/fr\/#website"},"datePublished":"2022-03-29T17:57:02+00:00","dateModified":"2022-03-29T17:59:44+00:00","description":"AB Science annonce aujourd\u2019hui avoir re\u00e7u l\u2019autorisation de l\u2019Agence de Sant\u00e9 Su\u00e9doise pour initier une \u00e9tude de Phase III (AB20009","breadcrumb":{"@id":"https:\/\/www.ab-science.com\/fr\/communication-dab-science-a-la-suite-de-la-decision-de-la-commission-des-sanctions-de-lautorite-des-marches-financiers\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ab-science.com\/fr\/communication-dab-science-a-la-suite-de-la-decision-de-la-commission-des-sanctions-de-lautorite-des-marches-financiers\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ab-science.com\/fr\/communication-dab-science-a-la-suite-de-la-decision-de-la-commission-des-sanctions-de-lautorite-des-marches-financiers\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.ab-science.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Communication d\u2019AB Science \u00e0 la suite de la d\u00e9cision de la Commission des sanctions de l\u2019Autorit\u00e9 des March\u00e9s Financiers"}]},{"@type":"WebSite","@id":"https:\/\/www.ab-science.com\/fr\/#website","url":"https:\/\/www.ab-science.com\/fr\/","name":"AB Science","description":"Masitinib and AB8939 \u2013 Two compounds with breakthrough mechanism of action","publisher":{"@id":"https:\/\/www.ab-science.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ab-science.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ab-science.com\/fr\/#organization","name":"AB Science","url":"https:\/\/www.ab-science.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ab-science.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ab-science.com\/wp-content\/uploads\/2020\/11\/logo_ab-science-wh120.png","contentUrl":"https:\/\/www.ab-science.com\/wp-content\/uploads\/2020\/11\/logo_ab-science-wh120.png","width":120,"height":120,"caption":"AB Science"},"image":{"@id":"https:\/\/www.ab-science.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/ab-science\/"]},{"@type":"Person","@id":"https:\/\/www.ab-science.com\/fr\/#\/schema\/person\/f22e8dbe9aaad0d416cbea66ecc4a755","name":"Alexis BERNARD","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/586e211c7d685fdd3428b70716f97574cf1b3149b055c1be5bdc5a7306e419bd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/586e211c7d685fdd3428b70716f97574cf1b3149b055c1be5bdc5a7306e419bd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/586e211c7d685fdd3428b70716f97574cf1b3149b055c1be5bdc5a7306e419bd?s=96&d=mm&r=g","caption":"Alexis BERNARD"},"url":"https:\/\/www.ab-science.com\/fr\/author\/abernard\/"}]}},"_links":{"self":[{"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/posts\/6693","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/comments?post=6693"}],"version-history":[{"count":0,"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/posts\/6693\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/media?parent=6693"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/categories?post=6693"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/tags?post=6693"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}